Search results
Think You Have Eczema? These Pictures Show Exactly How the Condition Manifests
Prevention via Yahoo News· 2 years agoEczema is a very common skin condition that affects over 30 million people in the United States,...
Roivant Sciences Highlights Topline Data From Atopic Dermatitis Drug In Patients As Young As 2 Years
Benzinga via Yahoo Finance· 1 year agoDermavant Sciences, a Roivant Sciences Ltd. (NASDAQ: ROIV) company, announced results from ADORING 2...
Do You Have Eczema? Here Are 5 Ways To Tell (And The Best Products For It)
BuzzFeed News via Yahoo News· 1 year agoAnna Efetova via Getty Images If you’re feeling itchy and dry these days, it’s a good idea to ask...
Eczema Causes and Symptom Triggers
Verywell Health via Yahoo News· 9 months agoEczema (atopic dermatitis) is a complex inflammatory skin condition that can occur at any age. It is estimated that 1 in 10 individuals will develop...
Regeneron (REGN) Gets Label Extension for Cholesterol Drug
Zacks via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals, Inc. REGN announced that the FDA has approved a label extension for the...
Here's Why You Should Invest in Aldeyra (ALDX) Stock Now
Zacks via Yahoo Finance· 2 months agoBurlington, MA-based Aldeyra Therapeutics ALDX is a leader in the development of RASP (reactive...
Biotech Stock Roundup: REGN, AMGN, MRNA's Q3 Earnings, VERV Down on Update
Zacks via Yahoo Finance· 1 year agoEarnings results, along with important regulatory and pipeline updates, continue to keep the biotech...
Why Is Incyte (INCY) Up 1.8% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 month agoIt has been about a month since the last earnings report for Incyte (INCY). Shares have added about...
Incyte (INCY) Up 3.3% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for Incyte (INCY). Shares have added about 3.3%...
4 Pharma, Biotech Stocks Poised to Beat Q1 Earnings Estimates
Zacks via Yahoo Finance· 1 year agoThe earnings season has just started for the drug/biotech sector, with bellwether Johnson & Johnson...